Composite biological scaffold for repairing nasal cartilage defect and preparation method thereof

By integrating 3D exosomes into the GelMA and PLGA composite scaffold, the sustained release function is achieved, which solves the problems of short exosome residence time and material waste in nasal septal cartilage defect repair, promotes the proliferation and matrix deposition of chondrocytes, and provides Effective mechanical support and biocompatibility have broad clinical application prospects.

CN119015501APending Publication Date: 2024-11-26THE 988TH HOSPITAL OF THE CHINESE PEOPLES LIBERATION ARMY JOINT LOGISTICS SUPPORT FORCE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410946874.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-16
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

In the prior art, when repairing nasal septum cartilage defects, the residence time of exosomes is short and the utilization rate of target sites is low, resulting in waste of materials, and artificial materials are prone to trigger rejection reactions and infections, and the stability is difficult to control.

Method used

Using Gel-PLGA composite biological scaffold, 3D exosomes were integrated into gelatin methacrylic acid (GelMA) and polylactic acid-glycolic acid (PLGA) composite scaffolds, and prepared by 3D coaxial printing technology to achieve sustained release of exosomes. Function, promotes the deposition of chondrocyte mesenchymal matrix and proliferation of chondrocytes.

Benefits of technology

It realizes sustained release of exosomes, promotes the healing of cartilage defects, provides mechanical support, improves the repair effect of nasal septum cartilage defects, and has good biocompatibility and clinical application prospects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015501A_ABST
    Figure CN119015501A_ABST
Patent Text Reader

Abstract

The invention provides a composite biological scaffold for repairing nasal cartilage defects and a preparation method thereof, and relates to the technical field of tissue engineering scaffolds. According to the Gel-PLGA / Exo composite biological scaffold, GelMA and PLGA are firstly used for preparing a composite scaffold, a 3D coaxial printing technology is used for successfully preparing 3D ADSCs-Exo, and after the 3D ADSCs-Exo is integrated into the Gel-PLGA composite scaffold, the Gel-PLGA / Exo composite biological scaffold capable of achieving the exosome slow release function is obtained. The Gel-PLGA / Exo composite biological scaffold provided by the invention has good biocompatibility, can promote the deposition of collagen at a healing part, realizes a repairing effect on a cartilage defect part, and has a wide prospect in clinical application as a cartilage defect repairing material.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of tissue engineering scaffolds, and in particular to a composite biological scaffold for repairing nasal cartilage defects and a preparation method thereof. Background Art

[0002] The nasal septum cartilage is hyaline cartilage without blood vessels, nerves and lymphatic vessels. The nasal septum cartilage is composed of about 1% chondrocytes and 99% extracellular matrix. At present, the most commonly used methods to repair nasal septum cartilage defects include prosthesis implantation or ear cartilage implantation, but the use of these materials has disadvantages such as secondary damage, difficulty in shaping, and easy absorption after implantation. Although artificial materials are easy to carve and difficult to absorb, they can cause rejection reactions and stimulate infection, and the stability of the materials cannot be well controlled.

[0003] A new treatment method has been proposed for cartilage defects, which uses exosomes (Exo) secreted by mesenchymal stem cells (MSC) to fill the defect. The main structure of Exo derived from MSC is a lipid molecule layer, which contains a variety of biological molecules such as nucleic acids and proteins, which can promote intercellular communication; due to the size of Exo, it is easily absorbed by cells, which allows Exo to release nucleic acids, proteins or cell genes in cells, and play a role in promoting intercellular communication and inducing tissue regeneration and repair. Studies have shown that Exo can effectively promote the deposition of chondrocyte interstitial matrix (ECM), promote the proliferation and migration of chondrocytes, and can be used as a new material for repairing cartilage defects.

[0004] However, directly injecting Exo into the damaged area has problems such as short residence time and low utilization rate of target sites, resulting in material waste. Therefore, it is urgent to develop a tissue engineering biomaterial for repairing nasal septum cartilage damage that can cache exosomes in the damaged area and continue to play a repair role, and can provide certain mechanical support for the damaged area. Summary of the invention

[0005] 1. Technical issues to be resolved

[0006] In view of the shortcomings of the prior art, a composite biological scaffold for repairing nasal cartilage defects and a preparation method thereof are provided. The present invention integrates the prepared 3D exosomes into the Gel-PLGA composite scaffold to obtain a Gel-PLGA / Exo composite biological scaffold that can achieve the exosome sustained release function. The composite biological scaffold can effectively release exosomes and effectively promote the deposition of chondrocyte interstitial matrix (ECM), accelerate the healing of cartilage defects, and achieve the repair effect on nasal cartilage defects.

[0007] (II) Technical solution

[0008] To achieve the above objectives, the present invention is implemented through the following technical solutions:

[0009] The present invention provides a composite biological scaffold for repairing nasal cartilage defects. The composite biological scaffold is prepared from gelatin methacrylate (GelMA), polylactic-glycolic acid (PLGA) and 3D exosomes (Exo) derived from adipose mesenchymal stem cells (ADSCs).

[0010] The present invention also provides a method for preparing a composite biological scaffold for repairing nasal cartilage defects. The composite biological scaffold is prepared according to the following steps:

[0011] (1) Obtaining 3D-derived ADSCs-Exo using coaxial printing:

[0012] S1: Use 1.5% alginate solution for shell flow and ADSCs cell suspension for core flow, with extrusion speeds of 20 mL / h and 5 mL / h, respectively, and use 3% CaCl2 as the receiving solution; the shell flow containing alginate solution will achieve rapid gelation in CaCl2, forming microfibers encapsulating cells after about 10 minutes; rinse the microfibers with 0.9% NaCl solution for 5 minutes, and move them to a 150 mm culture dish containing 25 mL MSC complete culture medium, and culture them in a 37°C, 5% CO2 incubator; collect the cell culture medium every 24 hours and replace it in time, and freeze the collected culture medium at -80°C;

[0013] S2: The cell culture medium is centrifuged and filtered continuously to collect exosomes; specifically: use an ultracentrifuge to precipitate at 300xg for 10 minutes at 4°C, and then precipitate at 2000xg for 30 minutes to remove dead cells. The remaining purified culture medium is centrifuged at 10000xg for 30 minutes, and the supernatant is filtered through a 0.22μm filter to remove excess protein; then, the supernatant is centrifuged at 100000xg for 70 minutes, the precipitate is washed with PBS, and the solution is transferred to a new tube and centrifuged again at 100000xg for 70 minutes to obtain 3D ADSCs-Exo;

[0014] (2) Preparation of PLGA scaffolds:

[0015] 2 g of PLGA particles were dissolved in hexafluoroisopropanol at 14.5% w / t and stirred for 2 h at room temperature. After the particles were completely dissolved, the solution was added to the electrospinning equipment. The discharge port was connected to the positive point of the high-voltage power supply, and the receiver was connected to the negative point of the high-voltage power supply. The voltage was set to 16 kV, the distance between the discharge port and the receiver was set to 17.5 cm, and the discharge flow rate of the solution was set to 15 μL / min. After electrospinning for 2 hours using a 5 ml syringe with an 18-G needle, the obtained biofilm was collected and placed in a 37°C drying oven overnight to obtain a PLGA scaffold.

[0016] (3) Preparation of Gel-PLGA / Exo composite scaffold

[0017] A certain mass of solid GelMA was dissolved in a photoinitiator solution at a solute-to-solution ratio of 10% under light-protected conditions, heated at 37°C and shaken for 40 minutes to obtain the desired GelMA hydrogel solution; 3D ADSCs-Exo was added to the GelMA hydrogel solution and mixed thoroughly, then a PLGA biofilm of appropriate size was cut and placed in a mold, and the prepared GelMA hydrogel solution containing 3D ADSCs-Exo was added to the mold, and the hydrogel was photocured using an ultraviolet light source to obtain a Gel-PLGA / Exo composite scaffold.

[0018] (III) Beneficial effects

[0019] The scaffold of the present invention is first prepared into a composite scaffold using GelMA and PLGA, and 3D ADSCs-Exo is successfully prepared using 3D coaxial printing technology. By integrating 3D ADSCs-Exo into the Gel-PLGA composite scaffold, we obtain a Gel-PLGA / Exo composite biological scaffold that can achieve the function of exosome sustained release. The composite biological scaffold has good biocompatibility, can promote the deposition of collagen in the healing site, and achieve the repair effect on the site of cartilage defects. The Gel-PLGA / Exo composite biological scaffold provided by the present invention has broad prospects in clinical applications as a material for cartilage defect repair. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 :(A) Observation of EVs morphology under TEM;(B) Analysis of EVs particle size by NTA;(C) Detection of EVs specific markers by WB protein blotting;(D) Cell uptake experiment.(E) Sustained release effect of composite scaffold on EVs.

[0021] Figure 2:(A) SEM photography of PLGA scaffold loaded with chondrocytes; (B) PLGA fiber diameter analysis; (C, D) swelling and degradation properties of Gel-PLGA composite scaffold; (E, F) tensile stress-strain curve and compressive stress-strain curve of Gel-PLGA composite scaffold; (G) FTIR detection of GelMA hydrogel loaded or not loaded with 3D ADSCs-Exo; (H) cell live-dead staining of scaffold; (I) cytotoxicity experiment of scaffold.

[0022] Figure 3 :Gel-PLGA scaffolds and Gel-PLGA / Exo composite scaffolds were used to repair the nasal septum defect in rabbits. The tissues were collected at the 6th and 12th weeks and HE staining was performed. Scale bar = 100 μm.

[0023] Figure 4 :Gel-PLGA scaffolds and Gel-PLGA / Exo composite scaffolds were used to repair the nasal septum defect in rabbits. The tissues were collected at the 6th and 12th weeks and stained with toluidine blue. Scale bars = 50 μm and 625 μm.

[0024] Figure 5 :Gel-PLGA scaffolds and Gel-PLGA / Exo composite scaffolds were used to repair the nasal septum defect in rabbits. The tissues were collected at the 6th and 12th weeks and subjected to ColⅡ immunohistochemical staining. Scale bars = 50μm and 625μm. DETAILED DESCRIPTION

[0025] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be clearly and completely described below in combination with the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0026] Example 1

[0027] 1 Preparation of GelMA-PLGA / Exo composite bioscaffold

[0028] 1.1 Obtaining 3D-derived ADSCs-Exo using coaxial printing:

[0029] S1: Use 1.5% alginate solution for shell flow and ADSCs cell suspension for core flow, with extrusion speeds of 20 mL / h and 5 mL / h, respectively, and use 3% CaCl2 as the receiving solution; the shell flow containing alginate solution will achieve rapid gelation in CaCl2, forming microfibers encapsulating cells after about 10 minutes; rinse the microfibers with 0.9% NaCl solution for 5 minutes, and move them to a 150 mm culture dish containing 25 mL MSC complete culture medium, and culture them in a 37°C, 5% CO2 incubator; collect the cell culture medium every 24 hours and replace it in time, and freeze the collected culture medium at -80°C;

[0030] S2: The cell culture medium is centrifuged and filtered continuously to collect exosomes; specifically: use an ultracentrifuge to precipitate at 300xg for 10 minutes at 4°C, and then precipitate at 2000xg for 30 minutes to remove dead cells. The remaining purified culture medium is centrifuged at 10000xg for 30 minutes, and the supernatant is filtered through a 0.22μm filter to remove excess protein; then, the supernatant is centrifuged at 100000xg for 70 minutes, the precipitate is washed with PBS, and the solution is transferred to a new tube and centrifuged again at 100000xg for 70 minutes to obtain 3D ADSCs-Exo;

[0031] 1.2 Preparation of PLGA scaffolds:

[0032] 2 g of PLGA particles were dissolved in hexafluoroisopropanol at 14.5% w / t and stirred for 2 h at room temperature. After the particles were completely dissolved, the solution was added to the electrospinning equipment. The discharge port was connected to the positive point of the high-voltage power supply, and the receiver was connected to the negative point of the high-voltage power supply. The voltage was set to 16 kV, the distance between the discharge port and the receiver was set to 17.5 cm, and the discharge flow rate of the solution was set to 15 μL / min. After electrospinning for 2 hours using a 5 ml syringe with an 18-G needle, the biofilm obtained was collected and placed in a 37°C drying oven overnight to obtain the PLGA scaffold.

[0033] 1.3 Preparation of Gel-PLGA composite scaffolds

[0034] A certain mass of solid GelMA was dissolved in a photoinitiator solution at a solute-to-solution ratio of 10% under light-proof conditions, heated at 37°C and shaken for 40 minutes to obtain the required GelMA hydrogel solution; a PLGA biofilm of appropriate size was cut and placed in a mold, and the prepared GelMA hydrogel solution was added to the mold, and the hydrogel was photocured into a gel using an ultraviolet light source for 30 seconds to obtain a Gel-PLGA composite scaffold.

[0035] 1.4 Preparation of Gel-PLGA / Exo composite bioscaffold

[0036] A certain mass of solid GelMA was dissolved in a photoinitiator solution at a solute-solution ratio of 10% under light-proof conditions, heated and shaken at 37°C for 40 min, 3D ADSCs-Exo was added to the GelMA hydrogel solution and mixed thoroughly, then a PLGA biofilm of appropriate size was cut and placed in a mold, and the prepared GelMA hydrogel solution containing 3D ADSCs-Exo was added to the mold, and the hydrogel was photocured using an ultraviolet light source for 30 s to obtain a Gel-PLGA / Exo composite scaffold;

[0037] 2 Characterization of 3D ADSCs-Exo

[0038] 2.1 Transmission electron microscopy (TME) observation of 3D ADSCs-Exo

[0039] 3D ADSCs-Exo were loaded onto Formvar carbon-coated EM copper grids, and the exosomes were stained with PKH26 kit (Sigma-Aldrich, USA). After air drying, the appearance of the exosomes was observed using a transmission electron microscope.

[0040] 2.2 Particle size analysis

[0041] The 3D ADSCs-Exo suspension was diluted to 1 mL and vortexed to mix, then transferred to a 1 mL syringe, and the particle size distribution of exosomes was detected using an NTA detector.

[0042] 2.3 Western blot detection (WB)

[0043] The protein concentration of 3D ADSCs-Exo was detected using a BCA kit according to the manufacturer's method, and the content of exosomes in each sample was calculated based on the test results. An appropriate amount of sodium dodecyl sulfate (SDS) buffer was added to the sample, and the protein denatured in 95°C water was electrophoresed after vortex mixing. After electrophoresis, the gel was separated, and the positive exosome protein markers CD63, CD81, and TSG101 and the negative protein marker calnexin in the gel were transferred to a polyvinylidene fluoride (PVDF) membrane. After blocking with 3% bovine serum albumin (BSA) blocking solution, the membrane was incubated with primary and secondary antibodies and developed.

[0044] Characterization of 3Gel-PLGA composite scaffolds

[0045] 3.1 Scanning electron microscope test

[0046] Scanning electron microscopy was used to characterize the microstructure of the electrospun PLGA biofilm and the Gel-PLGA composite scaffold. The biocompatibility of the scaffold and cells was observed by electron microscopy, and the fiber diameter of the scaffold was calculated using Origin2021. The specific operation is as follows: prepare a biological scaffold of appropriate size, evenly cover the surface of the scaffold with a suspension of nasal septal chondrocytes, and add 10% FBS in DMEM complete medium for 2 days. After the cells are fully attached to the wall and grow, wash the scaffold with PBS, freeze-dry the cell-loaded biofilm and composite scaffold, and use liquid nitrogen to brittle the composite scaffold to expose the cross section. Use an ion sputtering coater to spray gold on the surface of the scaffold at 18mA for 60s, take pictures with a scanning electron microscope, observe the surface morphology of the scaffold, and finally calculate the fiber diameter of the scaffold.

[0047] 3.2 Mechanical testing

[0048] The tensile and compressive properties of the Gel-PLGA composite scaffold were tested using a universal mechanical testing machine at a tensile and compressive speed of 10 mm / min. The stress-strain curves were plotted using Graphpad Prism2022.

[0049] 3.3 Swelling and degradation properties

[0050] Swelling performance: The weight of the freeze-dried Gel-PLGA composite scaffold was weighed as W0, and the scaffold was immersed in PBS solution. The PBS solution on the surface of the scaffold was absorbed with filter paper every 15 minutes, and the weight Wt was weighed. After 24 hours, the swelling weight of the scaffold was obtained. The calculation formula for the swelling of the scaffold is:

[0051] Swelling ratio (%) = (Wt-w0) / W0*100%

[0052] Degradation performance: The Gel-PLGA composite scaffold was placed in a PBS solution at a mass volume ratio of 0.04 g / ml. The samples were freeze-dried at 5, 10, 15, 20, 25, and 30 days, and the corresponding mass Wt was weighed. The calculation formula for scaffold degradation is:

[0053] Degradation rate(%)=(W0-Wt) / W0*100%

[0054] 4 Release test of 3D ADSCs-Exo in Gel-PLGA / Exo composite bioscaffold

[0055] The Gel-PLGA / Exo composite bioscaffold was placed in a dialysis bag and placed in a PBS solution, incubated at 37°C, and the PBS solution was collected on days 1, 2, 3, 4, 7, and 10. The exosome concentration in the solution was detected using a BCA kit, and the release curve of the exosomes was drawn. After each collection of exosomes, the PBS was replaced in time.

[0056] In addition, we investigated whether the addition of 3D ADSCs-Exo had an effect on the chemical functional groups of GelMA. The freeze-dried GelMA hydrogel mixed with 3D ADSCs-Exo and GelMA hydrogel were ground into powder samples, which were then fully mixed with potassium bromide samples. The treated samples were then analyzed using FT-RI at room temperature.

[0057] 5. Biocompatibility evaluation

[0058] 5.1 Cell live / dead staining experiment

[0059] 1*10 6 The cells were seeded on a 2cm*2cm Gel-PLGA composite scaffold and co-cultured with the Gel-PLGA composite scaffold for 1, 3, and 7 days; the Te staining solutions of AM and PI were added to the cell-laden composite scaffold at 0.5μL / ml using PBS solution until the working solution submerged the sample; the sample was incubated at 37°C for 30 minutes, and the sample was photographed and observed using a fluorescent inverted microscope.

[0060] 5.2 CCK-8 cytotoxicity assay

[0061] The GelMA hydrogel was immersed in DMEM complete culture medium at room temperature for 24 h in advance to obtain a solution containing the hydrogel extract; PLGA electrospun membranes of the same size were cut and placed on the bottom of a 96-well plate, 2000 cells were inoculated on the biofilm per well, and 100 μL of complete culture medium containing the hydrogel extract was added. The absorbance at 450 nm was measured on a microplate reader (Agilent, USA) using CCK-8 solution (beyotime, Shanghai, China) on days 1, 3, and 5 to evaluate the cell activity in each group of samples.

[0062] Repair effect of 6Gel-PLGA / Exo composite bioscaffold on nasal septal cartilage defect model in rabbits

[0063] 6.1 Modeling and grouping

[0064] Twelve adult New Zealand white rabbits (n=3 in each group, body weight 2-2.5 kg) were randomly divided into four groups: sham operation group, control group, Gel-PLGA group and Gel-PLGA / Exo group. The sham operation group did not receive any surgical treatment. The other three groups were anesthetized by injecting 2% sodium pentobarbital into the ear vein of the rabbits at a dose of 2 ml / kg after weighing the rabbits before surgery. Next, an incision of about 4 cm in length was exposed in the center of the rabbit's nasal bone, and a gap of about 2 cm in length and 1 cm in width was formed in the nasal bone at the center of the incision using a grinding drill to expose the nasal septum cartilage. An instrument was used to create a defect of 5 mm in length and width in the nasal septum cartilage. No treatment was performed on the control group. In the Gel-PLGA group, electrospun PLGA biofilm of the same size was cut and filled into the defect, and 10% GelMA solution was used to fill and photocured around the defect to achieve the effect of fixing the stent. At the same time, the difference between the Gel-PLGA / Exo group and the Gel-PLGA group was that a certain amount of exosomes were mixed with GelMA before injecting the hydrogel, and the photocuring time of all groups was set to 30 s. After surgery, the experimental animals in the surgical group were injected with penicillin for 3 consecutive days. The rabbits were killed by overdose anesthesia at 6 and 12 weeks after surgery, and the nasal septum samples were collected.

[0065] 6.2 Observation indicators

[0066] After fixation, decalcification, dehydration and paraffin embedding of the nasal septum samples, the samples were sliced ​​at 3 μm using a freezing microtome. The sections were stained with hematoxylin & eosin (H&E) and toluidine blue according to the instructions of the reagent manufacturer to observe the healing of the defect.

[0067] Immunohistochemical detection of type II collagen was performed on the sections, and the images of each group of sections were magnified and photographed at 100 times using a bright field microscope.

[0068] 7 Statistical analysis

[0069] GraphPad Prism 9.5 software and ImageJ were used for statistical analysis and all experiments were repeated at least three times. Data are expressed as mean ± standard deviation, and one-way analysis of variance was performed with Tukey's post hoc test for multiple comparisons, where P < 0.05 was considered statistically significant.

[0070] 8 Results

[0071] 8.1 Structural Characterization of 3D ADSCs-Exo

[0072] The coaxially printed 3D ADSCs-Exo were identified by particle size analysis, TEM, and Western blotting. Under TEM, exosomes were observed to have a circular or oval membrane structure ( Figure 1A); Particle size analysis shows that ( Figure 1 B), the diameter of exosomes ranges from about 120-150 nm. The extracted nanoparticles successfully expressed exosome surface-specific markers CD63 and TSG101 by Western blotting of exosomes ( Figure 1 C). Cellular uptake experiments showed that ( Figure 2 D), nasal septal chondrocytes can successfully absorb exosomes, and fluorescence microscopy shows that exosomes enter the cytoplasm through endocytosis and are enriched outside the nucleus. The experiment shows that we have successfully obtained 3DADSCs-Exo.

[0073] 8.2 Structural Characterization of Gel-PLGA / Exo Composite Bioscaffold

[0074] SEM observation of electrospun PLGA scaffolds showed that ( Figure 2 A), most of the fibers in the PLGA scaffold are approximately 1 μm in diameter ( Figure 2 B). The Gel-PLGA composite scaffold has a certain mechanical strength, showing the tensile modulus ( Figure 2 E) and compression modulus ( Figure 2 F) test results show that the tensile modulus of the scaffold is about 0.61MPa and the compression modulus is about 7.27MPa.

[0075] The swelling experiment found that the swelling rate of the Gel-PLGA composite scaffold reached 750% ( Figure 2 C). Degradation experiment ( Figure 3 D) shows that the composite scaffold can be continuously and stably degraded in PBS at 37°C, the hydrogel part degrades for about 30 days, while the degradation rate of the electrospun PLGA biofilm is slower.

[0076] The delayed release 3D ADSCs-Exo experiment showed ( Figure 1 E), in the first 3 days of the experiment, the release rate of exosomes was fast, but from the 4th day, the release rate of exosomes began to slow down, and by the 14th day, the total amount of exosomes released was close to 65%. The experimental results show that the Gel-PLGA / Exo composite scaffold can effectively achieve the sustained release effect of exosomes. FTIR detection shows that ( Figure 2 G), loading 3D ADSCs-Exo did not change the functional groups of GelMA hydrogel and would not affect the solidification of the scaffold.

[0077] 8.3 Biocompatibility

[0078] The biocompatibility of the scaffold is one of the important indicators for evaluating whether the scaffold can be implanted in the body. We used a cell live-death staining kit to evaluate the biocompatibility of the Gel-PLGA composite scaffold and tested the cell survival on days 1, 3, and 7 ( Figure 2H). Fluorescence microscopy showed that as the culture time increased, the number of cells in the Gel-PLGA composite scaffold also increased, and after seven days of culture, the cell density on the scaffold increased significantly compared to the first day. The Gel-PLGA composite scaffold can simulate the microstructure of cartilage in vitro. Under the microscope, it can be found that the cells inoculated in the scaffold gradually changed their morphology from the third day, from the long spindle-shaped structure in the 2D environment to a circular structure closer to the 3D environment in the body. Although some dead cells were detected by red fluorescence, most cells were still alive, which proves that the Gel-PLGA composite scaffold has excellent biocompatibility.

[0079] We also used the CCK-8 method to perform a digital analysis of the cytotoxicity of the scaffold. The cells were cultured with extracts of hydrogel, PLGA biofilm, and Gel-PLGA composite scaffold for 1, 3, and 5 days, respectively, and the absorbance of the liquid was measured by an ELISA instrument to evaluate the cytotoxicity of the scaffold ( Figure 2 I). The test showed that there was no statistical difference in the OD value between the composite scaffold and the normally cultured cells, and both increased with time, which further proved that the Gel-PLGA composite scaffold had good biocompatibility.

[0080] 8.4 Repair effect of Gel-PLGA / Exo composite bioscaffold on nasal septal cartilage defect model in rabbits

[0081] We created a 5 mm long and wide defect in the nasal septum of rabbits and took samples and observed the tissues at 6 and 12 weeks after stent implantation ( Figure 3 AB). We tested the swelling properties of the composite scaffold, so after implantation, the composite scaffold quickly absorbed the blood and body fluids near the tissue and swelled. All groups of experimental animals did not experience adverse reactions after surgery and survived well.

[0082] We set up a sham group, a control group, a Gel-PLGA scaffold group, and a Gel-PLGA / Exo composite bioscaffold group. The results of section staining are shown in Figure 3 D and Figure 4 A: HE staining ( Figure 3 D) and toluidine blue staining ( Figure 4A) The results showed that at week 6, compared with the control group, the Gel-PLGA group and the Gel-PLGA / Exo group began to heal to a certain extent at week 6, especially the Gel-PLGA / Exo group had new chondrocytes generated at the defect site, but there was still a certain difference in the cell arrangement compared with the sham group (Sham). At week 12, fibrous tissue filled the defect site in the Gel-PLGA group and a small amount of chondrocytes were generated. Toluidine blue staining showed that inflammation occurred at the site, causing the chondrocytes at the site to become hypertrophic. Due to the large defect site and the lack of sufficient cells and support for cell proliferation and migration, the defect site in the control group was not well repaired. At week 12, the Gel-PLGA / Exo group had basically achieved the repair of the defect site. It was observed that a large number of new chondrocytes were generated at the defect site. Thanks to the excellent anti-inflammatory ability of exosomes, these cells did not hypertrophy, and the overall arrangement of cells and chondrocyte extracellular matrix was close to that of the sham group.

[0083] Toluidine blue staining reflects the deposition of new tissue cartilage matrix. We normalized the stained tissue and the results showed that the Gel-PLGA / Exo group had more cartilage matrix deposition, and the Gel-PLGA group had a certain amount of cartilage matrix deposition, but there was a certain difference compared with the Gel-PLGA / Exo group. Figure 4 As shown in BC.

[0084] On the other hand, we performed immunohistochemical staining of ColⅡ at the defect site ( Figure 5 ), the staining results showed that the Gel-PLGA / Exo group had more positive reactions than the control group and the Gel-PLGA group at weeks 6 and 12. Observation of the pictures revealed that only some of the newly formed hypertrophic chondrocytes in the Gel-PLGA group expressed positive characteristics, while the overall collagen deposition in the Gel-PLGA / Exo group increased over time. The above results indicate that defects treated with Gel-PLGA / Exo showed better healing and collagen deposition.

[0085] 9 Discussions

[0086] As one of the hot topics in recent years, exosomes play an increasingly important role in tissue repair and organ function regulation. This invention is the first to use 3D printed exosomes combined with tissue engineering bioscaffolds to repair nasal septum defects. Exosomes have been widely used in the field of cartilage repair, but currently 2D-derived exosomes are mainly used for repair, and 3D-derived exosomes, especially in the field of nasal septum cartilage, have not yet been studied by scholars. Exosomes alone are difficult to repair cartilage defects, so we combine 3D-derived exosomes with tissue engineering biomaterials to further accelerate the repair of the defect while loading the exosomes.

[0087] The composite scaffold based on GelMA hydrogel and PLGA electrospinning biofilm can provide the necessary microenvironment and structure, and GelMA and PLGA have good biocompatibility. The diameter of the PLGA scaffold prepared by electrospinning in the present invention is about 1 μm. Under SEM, chondrocytes can be seen attached to the fibers and show the same circular structure as in vivo, which proves that the PLGA scaffold can effectively simulate the extracellular matrix of chondrocytes, thereby achieving the growth and proliferation of chondrocytes. The porous surface and hydrophilic properties of GelMA hydrogel are conducive to the adhesion of chondrocytes to its surface, and the ECM components contained in GelMA are conducive to promoting the formation and precipitation of the extracellular matrix of chondrocytes.

[0088] In vitro swelling experiments show that the Gel-PLGA scaffold can effectively absorb blood and other body fluids in the body. Sustained release ability is also one of the important indicators for testing the applicability of the scaffold. Exosomes have a strong self-decomposition ability, and GelMA hydrogel can achieve the sustained release effect of exosomes at the defect site. The experiment found that the Gel-PLGA / Exo composite bioscaffold can slowly release exosomes within 14 days. Although the cartilage of the nasal septum does not have the same load-bearing requirements as the knee or vertebral joint cartilage, due to the special location of this part, if it collapses, it will affect the patient's appearance, so the implanted material needs to have certain mechanical properties to support the defect. In this experiment, we measured the tensile and compression moduli of the Gel-PLGA composite scaffold. The experimental results show that the Gel-PLGA composite scaffold has strong tensile ductility and can withstand a high compression modulus. Its mechanical strength is sufficient to support the defective parts.

[0089] The repair of cartilage defects is inseparable from chondrocytes. Like other hyaline cartilages, the cell content in the nasal septum cartilage is also low and the repair ability is weak. By adding Exo to the Gel-PLGA composite scaffold, we can effectively promote the proliferation and migration of chondrocytes and improve the ability of chondrocytes to secrete extracellular matrix. In the process of cartilage repair, the formation of extracellular matrix such as Col II and ACAN is crucial, and this matrix is ​​mainly secreted by chondrocytes. Therefore, promoting the generation of chondrocytes in defective tissues becomes the key to repair. The in vivo immunohistochemistry experiment of Col II found that the addition of Exo promoted the deposition ability of tissue collagen and further accelerated tissue repair.

[0090] 10 Conclusion

[0091] The present invention provides a composite scaffold based on GelMA and PLGA, and successfully prepares 3D ADSCs-Exo by using 3D coaxial printing technology. By integrating 3D ADSCs-Exo into the composite scaffold, we obtain a Gel-PLGA / Exo composite biological scaffold that can realize the exosome sustained release function. The composite biological scaffold has good biocompatibility, can promote the deposition of collagen in the healing site, and achieve the repair effect on the site of cartilage defects. The Gel-PLGA / Exo composite biological scaffold provided by the present invention has broad prospects in clinical applications as a material for repairing cartilage defects.

[0092] The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit the same. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that the technical solutions described in the aforementioned embodiments may still be modified, or some of the technical features may be replaced by equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. A composite biological scaffold for repairing nasal cartilage defects, characterized in that: The composite biological scaffold is prepared from gelatin methacrylate GelMA, polylactic acid-glycolic acid PLGA and 3D exosomes Exo derived from adipose mesenchymal stem cells ADSCs.

2. The method for preparing a composite biological scaffold for repairing nasal cartilage defects according to claim 1, characterized in that: The composite bioscaffold is prepared according to the following steps: (1) Obtaining 3D-derived ADSCs-Exo using coaxial printing: S1: Use 1.5% alginate solution for shell flow and ADSCs cell suspension for core flow, with extrusion speeds of 20 mL / h and 5 mL / h, respectively, and use 3% CaCl2 as the receiving solution; the shell flow containing alginate solution will achieve rapid gelation in CaCl2, forming microfibers encapsulating cells after about 10 minutes; rinse the microfibers with 0.9% NaCl solution for 5 minutes, and move them to a 150 mm culture dish containing 25 mL MSC complete culture medium, and culture them in a 37°C, 5% CO2 incubator; collect the cell culture medium every 24 hours and replace it in time, and freeze the collected culture medium at -80°C; S2: The cell culture medium is centrifuged and filtered continuously to collect exosomes; specifically: use an ultracentrifuge to precipitate at 300xg for 10 minutes at 4°C, and then precipitate at 2000xg for 30 minutes to remove dead cells. The remaining purified culture medium is centrifuged at 10000xg for 30 minutes, and the supernatant is filtered through a 0.22μm filter to remove excess protein; then, the supernatant is centrifuged at 100000xg for 70 minutes, the precipitate is washed with PBS, and the solution is transferred to a new tube and centrifuged again at 100000xg for 70 minutes to obtain 3D ADSCs-Exo; (2) Preparation of PLGA biofilm: 2 g of PLGA particles were dissolved in hexafluoroisopropanol at 14.5% w / t and stirred for 2 h at room temperature. After the particles were completely dissolved, the solution was added to the electrospinning equipment. The discharge port was connected to the positive point of the high-voltage power supply, and the receiver was connected to the negative point of the high-voltage power supply. The voltage was set to 16 kV, the distance between the discharge port and the receiver was set to 17.5 cm, and the discharge flow rate of the solution was set to 15 μL / min. After electrospinning for 2 hours using a 5 ml syringe with an 18-G needle, the obtained biofilm was collected and placed in a 37°C drying oven overnight to obtain the PLGA biofilm. (3) Preparation of Gel-PLGA / Exo composite scaffold A certain mass of solid GelMA was dissolved in a photoinitiator solution at a solute-to-solution ratio of 10% under light-proof conditions, heated at 37°C and shaken for 40 minutes to obtain the desired GelMA hydrogel solution; 3DADSCs-Exo was added to the GelMA hydrogel solution and mixed thoroughly. Then, a PLGA biofilm of appropriate size was cut and placed in a mold. The prepared GelMA hydrogel solution containing 3DADSCs-Exo was added to the mold. The hydrogel was photocured using an ultraviolet light source to obtain a Gel-PLGA / Exo composite scaffold.